




Searching News Database: Alcon
HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
HSMN NewsFeed - 4 Nov 2016
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
HSMN NewsFeed - 7 Oct 2016
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
HSMN NewsFeed - 12 Jan 2016
ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment
ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
HSMN NewsFeed - 23 Jul 2013
BIOLASE Names Medical Device Marketing Veteran Orlando Rodrigues as Vice President, Marketing
BIOLASE Names Medical Device Marketing Veteran Orlando Rodrigues as Vice President, Marketing
HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
HSMN NewsFeed - 17 Dec 2012
Andrew Technologies Receives FDA 510(k) Clearance for Commercial Version of HydraSolve(TM) Lipoplasty System
Andrew Technologies Receives FDA 510(k) Clearance for Commercial Version of HydraSolve(TM) Lipoplasty System
HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
HSMN NewsFeed - 4 May 2012
New HydraSolve(TM) Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
New HydraSolve(TM) Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
HSMN NewsFeed - 19 Sep 2011
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
HSMN NewsFeed - 28 Sep 2010
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
HSMN NewsFeed - 3 Sep 2010
Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside the United States
Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside the United States
HSMN NewsFeed - 11 Feb 2010
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
OXiGENE Announces Restructuring to Focus Resources on Key Programs and Provides Business Update
HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 2 Jul 2009
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
HSMN NewsFeed - 19 May 2009
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
HSMN NewsFeed - 15 Sep 2008
Alcon Launches New AcrySof(R) ReSTOR(R) Intraocular Lens for Presbyopia Outside the U.S.
Alcon Launches New AcrySof(R) ReSTOR(R) Intraocular Lens for Presbyopia Outside the U.S.
HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
HSMN NewsFeed - 1 Jul 2008
Bausch & Lomb Names Dr. John W. Sheets, Jr., as Corporate Vice President and Chief Technology Officer
Bausch & Lomb Names Dr. John W. Sheets, Jr., as Corporate Vice President and Chief Technology Officer
HSMN NewsFeed - 24 Jun 2008
Advanced Medical Optics Enters into Cross-Licensing Patent Agreement with Alcon
Advanced Medical Optics Enters into Cross-Licensing Patent Agreement with Alcon
HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
HSMN NewsFeed - 10 Mar 2008
Alcon Announces Leadership Change to Research and Development Organization
Alcon Announces Leadership Change to Research and Development Organization
HSMN NewsFeed - 28 Sep 2007
Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
HSMN NewsFeed - 14 Jun 2007
STAAR Surgical Creates New Leadership Position to Oversee Research, Development and Clinical Activities
STAAR Surgical Creates New Leadership Position to Oversee Research, Development and Clinical Activities
HSMN NewsFeed - 12 Jun 2007
Mark J. Forchette Named President and Chief Executive Officer of OptiMedica(R)
Mark J. Forchette Named President and Chief Executive Officer of OptiMedica(R)
HSMN NewsFeed - 22 Mar 2007
North American Scientific Names John Rush to Serve as President and Chief Executive Officer
North American Scientific Names John Rush to Serve as President and Chief Executive Officer
HSMN NewsFeed - 1 Feb 2007
Alcon's AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved by FDA
Alcon's AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved by FDA
HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
HSMN NewsFeed - 18 Sep 2006
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
HSMN NewsFeed - 18 Sep 2006
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
HSMN NewsFeed - 10 Jul 2006
Advanced Medical Optics Announces Settlement With Alcon of Patent Infringement Suits
Advanced Medical Optics Announces Settlement With Alcon of Patent Infringement Suits
HSMN NewsFeed - 8 May 2006
Alcon Gains FDA Approval for LADAR6000(TM) Excimer Laser and Wavefront-Guided Hyperopia
Alcon Gains FDA Approval for LADAR6000(TM) Excimer Laser and Wavefront-Guided Hyperopia
Additional items found! 33

Members Archive contains
33 additional stories matching:
Alcon
(Password required)
Alcon
(Password required)